Esperion Therapeutics
ESPR
#8317
Rank
โ‚ฌ0.15 B
Marketcap
0,78ย โ‚ฌ
Share price
-7.15%
Change (1 day)
-60.93%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -2,68ย โ‚ฌ

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -2,49ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,13ย โ‚ฌ an increase over its 2021 EPS that were of -8,44ย โ‚ฌ.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,68ย โ‚ฌ-14.44%
2022-3,13ย โ‚ฌ-62.87%
2021-8,44ย โ‚ฌ80.38%
2020-4,68ย โ‚ฌ50.14%
2019-3,11ย โ‚ฌ-53.18%
2018-6,65ย โ‚ฌ7.41%
2017-6,19ย โ‚ฌ110.81%
2016-2,94ย โ‚ฌ47.35%
2015-1,99ย โ‚ฌ0.89%
2014-1,98ย โ‚ฌ28.84%
2013-1,53ย โ‚ฌ-89.3%
2012-14,34ย โ‚ฌ
2002-6,04ย โ‚ฌ8.89%
2001-5,55ย โ‚ฌ-83.77%
2000-34,19ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-9,04ย โ‚ฌ 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
0,69ย โ‚ฌ-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
1,64ย โ‚ฌ-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
32,97ย โ‚ฌ-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,56ย โ‚ฌ-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,60ย โ‚ฌ-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA